Efficacy of Nivolumab in routine clinical practice at a single center in patients with advanced NSCLC.
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Nivolumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Nov 2017 New trial record
- 18 Oct 2017 Results presented at the 18th World Conference on Lung Cancer.